|
|
Options for no-option patientsAdvanced CAD treatment |
|||||||||||||||||||||||||||||||||||||
The Angiogenesis Research Center at the Beth Israel Deaconess Medical Center and Harvard Medical School provides cutting edge investigational treatment strategies for patients with ischemic heart disease and peripheral vascular disease. Often patients without any standard options referred for consideration of experimental therapy end up being candidates for advanced standard therapies such as revascularization of chronic total occlusion in heart and peripheral vessels, carotid stenting, left ventricular support devices and advanced structural procedures.